Skip to content
Screener

Moderna MRNA Current ratio

Current ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Novavax logo
NovavaxNVAX
2.5×+0.4×
ALN
Alnylam PharmaceuticalsALNY
3.1×+0.3×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-0.4×
Roivant Sciences logo
Roivant SciencesROIV
18.4×-15.1×
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
7.5×-10.2×

Other financials

Income statement

See full
Revenue$145.0M+2.1%
Gross profit$52.0M+126%
Operating income-$815.0M+10.1%
Net income-$782.0M+5.2%
EPS (diluted)-$1.97+7.5%

Balance sheet

See full
Cash & equivalents$1.7B+34.5%
Total debt$1.2B+60.8%
Total equity$6.8B-28.1%
Total assets$11.0B-8.7%

Cash flow

See full
Operating cash flow-$526.0M+42.8%
CapEx$37.0M+1,133%
Free cash flow-$563.0M+38.9%

Valuation

See full
Market cap$21.75B+102%
Enterprise value$21.26B+108%
P/S9.8×+6.3×

Profitability

See full
Gross margin23.4%-29.1pp
Operating margin-149%+99.9pp
Net margin-141.4%+141pp
FCF margin-132.4%

Returns & leverage

See full
Return on equity-39%+28.0pp
Debt / equity0.2×+0.1×

Where this comes from

Calculated from Moderna’s reported figures.

Based on the most recent quarter.

The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →

Filed
Jul 31, 2026, 7:03 AM EDT
Accession
0001682852-26-000147

FAQ

What is Moderna's current ratio?
Moderna (MRNA) reported current ratio of 2.3× in Q2 2026.
How has Moderna's current ratio changed year-over-year?
Moderna's current ratio decreased by 41.5% year-over-year, from 3.9× to 2.3×.
What is the long-term trend for Moderna's current ratio?
Over 5 years (2020 to 2025), Moderna's current ratio has grown at a 18.1% compound annual growth rate (CAGR), from 1.4× to 3.3×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Moderna's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude